Laparoscopic vs Open Appendectomy in Obese Patients
Evaluation of Post Operative Outcomes of Laparoscopic and Open Appendectomy in Obese Patients
1 other identifier
interventional
166
0 countries
N/A
Brief Summary
Acute appendicitis is one of the most common surgical emergencies globally. While surgical removal of the appendix (appendectomy) is the definitive treatment, the optimal surgical approach-laparoscopic versus open-remains widely debated, particularly in obese patients. Obese individuals present unique surgical challenges due to increased abdominal wall thickness, which often necessitates larger skin incisions during open procedures, potentially increasing postoperative pain, wound healing times, and wound complications. This study aims to compare the postoperative outcomes of laparoscopic appendectomy versus standard open appendectomy in obese patients (BMI ≥ 30 kg/m²) presenting with acute appendicitis. Participants will be randomly assigned to undergo either open appendectomy or laparoscopic appendectomy. The primary outcomes evaluated will be the incidence of surgical site infections (including superficial wound infections and intra-abdominal abscesses) up to 30 days post-procedure and the total length of hospital stay (in days).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2026
CompletedFirst Posted
Study publicly available on registry
September 16, 2026
CompletedStudy Start
First participant enrolled
October 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 2, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
September 16, 2026
September 1, 2026
6 months
September 9, 2026
September 10, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Incidence of Surgical Site Infection (SSI)
Proportion of patients who develop a surgical site infection, defined as either superficial/deep wound infection (presence of purulent discharge, erythema, localized swelling, or requiring reopening) or intra-abdominal abscess (confirmed via ultrasound in patients presenting with abdominal pain, fever, or fullness)
Up to 30 days postoperatively
Length of Hospital Stay
The total number of days the patient remained in the hospital postoperatively until meeting discharge criteria (afebrile, tolerating a regular diet, and achieving good pain control).
From day of surgery up to discharge (up to 30 days postoperatively)
Study Arms (2)
Open Appendectomy
ACTIVE COMPARATORParticipants undergo open appendectomy using a standard grid-iron incision under general anesthesia. Appendiceal base ligation and closure are performed in standard anatomical layers.
Group 2: Laparoscopic Appendectomy
EXPERIMENTALParticipants undergo laparoscopic appendectomy using a standard 3-port technique (umbilical, left iliac fossa, and lower midline ports) under general anesthesia.
Interventions
Open surgical removal of the appendix performed via a standard grid-iron incision under general anesthesia with standard prophylactic antibiotics.
Laparoscopic surgical removal of the appendix using a standard 3-port configuration (umbilical, left iliac fossa, and lower midline ports) under general anesthesia with standard prophylactic antibiotics.
Eligibility Criteria
You may qualify if:
- Obese patients with Body Mass Index (BMI) ≥ 30 kg/m².
- Clinical diagnosis of acute appendicitis based on Alvarado score (history of right lower quadrant or periumbilical pain shifting to RLQ, nausea and/or vomiting, fever \> 38 °C, RLQ guarding and tenderness, and/or leukocytosis \> 10,000 cells/mL).
- Age between 15 and 50 years.
- Both male and female patients.
You may not qualify if:
- Immunocompromised patients (e.g., HIV infection or current steroid therapy).
- History of prior chemotherapy, radiotherapy, or recurrent infections.
- History of drug or alcohol abuse.
- Severe hepatic, renal, or cardiovascular dysfunction.
- History of previous abdominal surgery.
- Appendicular malignancy.
- Pregnant women.
- Preoperative findings indicating appendiceal perforation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
September 9, 2026
First Posted
September 16, 2026
Study Start
October 2, 2026
Primary Completion (Estimated)
April 2, 2027
Study Completion (Estimated)
April 30, 2027
Last Updated
September 16, 2026
Record last verified: 2026-09